PHASE-I AND PHARMACOKINETIC STUDY OF 5-AZA-2'-DEOXYCYTIDINE (NSC 127716) IN CANCER-PATIENTS

被引：1
|
作者：
VANGROENINGEN, CJ
LEYVA, A
OBRIEN, AMP
GALL, HE
PINEDO, HM
机构：
来源：
CANCER RESEARCH | 1986年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4831 / 4836
页数：6
相关论文
共 50 条
  • [41] PHASE-I AND PHARMACOKINETIC STUDY OF ARABINOFURANOSYL-5-AZACYTOSINE (FAZARABINE, NSC-281272)
    SURBONE, A
    FORD, H
    KELLEY, JA
    BENBARUCH, N
    THOMAS, RV
    FINE, R
    COWAN, KH
    CANCER RESEARCH, 1990, 50 (04) : 1220 - 1225
  • [42] 5-aza-2′-deoxycytidine induces telomere dysfunction in breast cancer cells
    Al-dulaimi, Sarah
    Matta, Sheila
    Slijepcevic, Predrag
    Roberts, Terry
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 178
  • [43] The mechanism of 5-aza-2′-deoxycytidine-mediated cytotoxicity in the treatment of cancer
    Sankpal, Umesh T.
    Robertson, Keith
    CANCER RESEARCH, 2006, 66 (08)
  • [44] Mechanisms of resistance to 5-aza-2′-deoxycytidine in human cancer cell lines
    Qin, Taichun
    Jelinek, Jaroslav
    Si, Jiali
    Shu, Jingmin
    Issa, Jean-Pierre J.
    BLOOD, 2009, 113 (03) : 659 - 667
  • [45] Anticancer efficacy of cisplatin and trichostatin A 5-aza-2′-deoxycytidine on ovarian cancer
    Meng, F.
    Sun, G.
    Zhong, M.
    Yu, Y.
    Brewer, M. A.
    BRITISH JOURNAL OF CANCER, 2013, 108 (03) : 579 - 586
  • [46] PHASE-I TRIAL OF RETINOL IN CANCER-PATIENTS
    GOODMAN, GE
    ALBERTS, DS
    EARNST, DL
    MEYSKENS, FL
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (06) : 394 - 399
  • [47] Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
    Metin Karahoca
    Richard L Momparler
    Clinical Epigenetics, 2013, 5
  • [48] PHASE-I TRIAL OF THYMOSIN FRACTION-5 IN CANCER-PATIENTS
    FABREGA, R
    PINSKY, C
    BRAUN, D
    CHUNG, T
    KROWN, S
    OETTGEN, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 126 - 126
  • [49] 5-AZA-2′-deoxycytidine in cancer immunotherapy:: A mouse to man story -: Response
    Guo, Z. Sheng
    Restifo, Nicholas P.
    Schrump, David S.
    CANCER RESEARCH, 2007, 67 (06) : 2901 - 2902
  • [50] Pharmacokinetic and pharmacodynamic analysis of 5-aza-2′-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
    Karahoca, Metin
    Momparler, Richard L.
    CLINICAL EPIGENETICS, 2013, 5
12345